OPTA2 generally develops in late childhood or early adulthood and exhibits a milder phenotype, and is therefore classified as a “benign” form of osteopetrosis, with a frequency of about 5.5 in 100,000 people [6]. Here, CLCN7 is linked to osteopetrosis.